{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:01:15Z","timestamp":1785193275944,"version":"3.55.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Bakar Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"The Leone-Perkins Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of the Review<\/jats:title>\n                <jats:p>Results from epidemiological studies suggest that vitamin D (VD) deficiency (VDD) may be a cause of hypertension (HTN). However, the results of randomized clinical trials (RCTs) designed to address the impact of VD supplementation on reducing blood pressure (BP) remain equivocal. To determine whether VD might serve as a beneficial treatment option for a specific subset of hypertensive patients, we performed a stratified analysis of RCT data and addressed problems associated with some methodological issues.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>HTN is caused by multiple factors. VDD may be one of the factors contributing to the development of this disorder. There are more than 70 RCTs that examined the impact of VD supplementation on BP. These RCTs can be classified into four groups based on their respective study populations, including participants who are (1) VD-sufficient and normotensive, (2) VD-deficient and normotensive, (3) VD-sufficient and hypertensive, and (4) VD-deficient and hypertensive.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>Our evaluation of these studies demonstrates that VD supplementation is ineffective when used to reduce BP in VD-sufficient normotensive subjects. VD supplementation for five years or more may reduce the risk of developing HTN specifically among those with VDD. Interestingly, findings from 12 RCTs indicate that daily or weekly supplementation, as opposed to large bolus dosing, results in the reduction of BP in VD-deficient hypertensive patients. Our ongoing research focused on elucidating the mechanisms of VDD-induced HTN will ultimately provide evidence to support the development of etiology-specific prevention and treatment strategies focused on HTN in the VD-deficient population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11906-022-01204-6","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T14:03:59Z","timestamp":1655993039000},"page":"445-453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Is Vitamin D Supplementation an Effective Treatment for Hypertension?"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5076-8718","authenticated-orcid":false,"given":"Songcang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gio","family":"Gemelga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yerem","family":"Yeghiazarians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"issue":"18","key":"1204_CR1","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1001\/jama.2020.20356","volume":"324","author":"JM Adams","year":"2020","unstructured":"Adams JM, Wright JS. A National Commitment to Improve the Care of Patients With Hypertension in the US. JAMA. 2020;324(18):1825\u20136. https:\/\/doi.org\/10.1001\/jama.2020.20356.","journal-title":"JAMA"},{"issue":"2","key":"1204_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ccl.2016.12.005","volume":"35","author":"KC Ferdinand","year":"2017","unstructured":"Ferdinand KC, Nasser SA. Management of Essential Hypertension. Cardiol Clin. 2017;35(2):231\u201346. https:\/\/doi.org\/10.1016\/j.ccl.2016.12.005.","journal-title":"Cardiol Clin"},{"issue":"9","key":"1204_CR3","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/CIRCULATIONAHA.111.030189","volume":"124","author":"BM Egan","year":"2011","unstructured":"Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011;124(9):1046\u201358. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.030189.","journal-title":"Circulation"},{"issue":"12","key":"1204_CR4","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jama.2020.14545","volume":"324","author":"P Muntner","year":"2020","unstructured":"\u2022\u2022 Muntner P, Hardy ST, Fine LJ, Jaeger BC, Wozniak G, Levitan EB, et al. Trends in Blood Pressure Control Among US Adults With Hypertension, 1999\u20132000 to 2017\u20132018. JAMA. 2020;324(12):1190\u2013200. https:\/\/doi.org\/10.1001\/jama.2020.14545. This study shows the HTN control trends among US adult patients recently.","journal-title":"JAMA"},{"issue":"1","key":"1204_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/HJH.0b013e32834ee23c","volume":"30","author":"S Chen","year":"2012","unstructured":"Chen S. Essential hypertension: perspectives and future directions. J Hypertens. 2012;30(1):42\u20135. https:\/\/doi.org\/10.1097\/HJH.0b013e32834ee23c.","journal-title":"J Hypertens"},{"issue":"1","key":"1204_CR6","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1016\/S2214-109X(19)30457-7","volume":"8","author":"RM Mogire","year":"2020","unstructured":"Mogire RM, Mutua A, Kimita W, Kamau A, Bejon P, Pettifor JM, et al. Prevalence of vitamin D deficiency in Africa: a systematic review and meta-analysis. Lancet Glob Health. 2020;8(1):e134\u201342. https:\/\/doi.org\/10.1016\/S2214-109X(19)30457-7.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"1204_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/jc.2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53\u20138. https:\/\/doi.org\/10.1210\/jc.2010-2704.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1204_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jash.2015.08.009","volume":"9","author":"S Chen","year":"2015","unstructured":"Chen S, Sun Y, Agrawal DK. Vitamin D deficiency and essential hypertension. J Am Soc Hypertens. 2015;9(11):885\u2013901. https:\/\/doi.org\/10.1016\/j.jash.2015.08.009.","journal-title":"J Am Soc Hypertens"},{"key":"1204_CR9","doi-asserted-by":"publisher","DOI":"10.4172\/2169-0138.1000147","author":"S Chen","year":"2017","unstructured":"Chen S. Effect of Vitamin D on the Treatment and Prevention of Essential Hypertension. Drug Designing: Open Access. 2017. https:\/\/doi.org\/10.4172\/2169-0138.1000147.","journal-title":"Drug Designing: Open Access."},{"issue":"1","key":"1204_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/nure.12090","volume":"72","author":"RP Heaney","year":"2014","unstructured":"Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev. 2014;72(1):48\u201354. https:\/\/doi.org\/10.1111\/nure.12090.","journal-title":"Nutr Rev"},{"issue":"6","key":"1204_CR11","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269\u2013324. https:\/\/doi.org\/10.1161\/HYP.0000000000000066.","journal-title":"Hypertension"},{"issue":"6","key":"1204_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMp1716193","volume":"378","author":"G Bakris","year":"2018","unstructured":"Bakris G, Sorrentino M. Redefining Hypertension - Assessing the New Blood-Pressure Guidelines. N Engl J Med. 2018;378(6):497\u20139. https:\/\/doi.org\/10.1056\/NEJMp1716193.","journal-title":"N Engl J Med"},{"issue":"9129","key":"1204_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(05)60827-6","volume":"352","author":"R Krause","year":"1998","unstructured":"Krause R, Buhring M, Hopfenmuller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure. Lancet. 1998;352(9129):709\u201310. https:\/\/doi.org\/10.1016\/S0140-6736(05)60827-6.","journal-title":"Lancet"},{"issue":"2","key":"1204_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1172\/JCI15219","volume":"110","author":"YC Li","year":"2002","unstructured":"Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110(2):229\u201338. https:\/\/doi.org\/10.1172\/JCI15219.","journal-title":"J Clin Invest"},{"key":"1204_CR15","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Giustina A, Adler RA, Binkley N, Bollerslev J, Bouillon R, Dawson-Hughes B, et al. Consensus statement from 2(nd) International Conference on Controversies in Vitamin D. Rev Endocr Metab Disord. 2020;21(1):89\u2013116. https:\/\/doi.org\/10.1007\/s11154-019-09532-w. A statement from the second VD International Conference emphasizes that low or high doses of VD may be inefficient because a U-shape relationship exists between VD doses and its outcomes, and that a non-intermittent regimen is important for a successful intervention.","DOI":"10.1007\/s11154-019-09532-w"},{"issue":"12","key":"1204_CR16","doi-asserted-by":"publisher","first-page":"e10417","DOI":"10.1002\/jbm4.10417","volume":"4","author":"A Giustina","year":"2020","unstructured":"\u2022\u2022 Giustina A, Bouillon R, Binkley N, Sempos C, Adler RA, Bollerslev J, et al. Controversies in Vitamin D: A Statement From the Third International Conference. JBMR Plus. 2020;4(12):e10417. https:\/\/doi.org\/10.1002\/jbm4.10417. A statement from the Third VD International Conference highlights that the conclusion that VD has no effect on cardiovascular system and cancer from recent large RCTs is not evidence-based to claim because the trials did not target the populations who were VD-deficient.","journal-title":"JBMR Plus"},{"issue":"2","key":"1204_CR17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.atherosclerosis.2015.04.795","volume":"240","author":"AD Gepner","year":"2015","unstructured":"Gepner AD, Haller IV, Krueger DC, Korcarz CE, Binkley N, Stein JH. A randomized controlled trial of the effects of vitamin D supplementation on arterial stiffness and aortic blood pressure in Native American women. Atherosclerosis. 2015;240(2):526\u20138. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.04.795.","journal-title":"Atherosclerosis"},{"issue":"5","key":"1204_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1365-2796.2009.02181.x","volume":"267","author":"R Jorde","year":"2010","unstructured":"Jorde R, Sneve M, Torjesen P, Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med. 2010;267(5):462\u201372. https:\/\/doi.org\/10.1111\/j.1365-2796.2009.02181.x.","journal-title":"J Intern Med"},{"issue":"1","key":"1204_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10654-013-9874-z","volume":"29","author":"SK Kunutsor","year":"2014","unstructured":"Kunutsor SK, Burgess S, Munroe PB, Khan H. Vitamin D and high blood pressure: causal association or epiphenomenon? Eur J Epidemiol. 2014;29(1):1\u201314. https:\/\/doi.org\/10.1007\/s10654-013-9874-z.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"1204_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa1809944","volume":"380","author":"JE Manson","year":"2019","unstructured":"Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1809944.","journal-title":"N Engl J Med"},{"issue":"3","key":"1204_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1161\/CIRCULATIONAHA.114.011732","volume":"131","author":"P Arora","year":"2015","unstructured":"Arora P, Song Y, Dusek J, Plotnikoff G, Sabatine MS, Cheng S, et al. Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation. 2015;131(3):254\u201362. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.011732.","journal-title":"Circulation"},{"issue":"8","key":"1204_CR22","doi-asserted-by":"publisher","first-page":"e0160905","DOI":"10.1371\/journal.pone.0160905","volume":"11","author":"I Bressendorff","year":"2016","unstructured":"Bressendorff I, Brandi L, Schou M, Nygaard B, Frandsen NE, Rasmussen K, et al. The Effect of High Dose Cholecalciferol on Arterial Stiffness and Peripheral and Central Blood Pressure in Healthy Humans: A Randomized Controlled Trial. PLoS ONE. 2016;11(8):e0160905. https:\/\/doi.org\/10.1371\/journal.pone.0160905.","journal-title":"PLoS ONE"},{"issue":"1","key":"1204_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1464-5491.2008.02636.x","volume":"26","author":"J Nagpal","year":"2009","unstructured":"Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med. 2009;26(1):19\u201327. https:\/\/doi.org\/10.1111\/j.1464-5491.2008.02636.x.","journal-title":"Diabet Med"},{"issue":"4","key":"1204_CR24","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/ajcn\/83.4.754","volume":"83","author":"SS Schleithoff","year":"2006","unstructured":"Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83(4):754\u20139. https:\/\/doi.org\/10.1093\/ajcn\/83.4.754.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"1204_CR25","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/HJH.0b013e328349666d","volume":"29","author":"R Scragg","year":"2011","unstructured":"Scragg R, Wishart J, Stewart A, Ofanoa M, Kerse N, Dyall L, et al. No effect of ultraviolet radiation on blood pressure and other cardiovascular risk factors. J Hypertens. 2011;29(9):1749\u201356. https:\/\/doi.org\/10.1097\/HJH.0b013e328349666d.","journal-title":"J Hypertens"},{"issue":"2","key":"1204_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00394-015-1106-8","volume":"56","author":"E Seibert","year":"2017","unstructured":"Seibert E, Lehmann U, Riedel A, Ulrich C, Hirche F, Brandsch C, et al. Vitamin D3 supplementation does not modify cardiovascular risk profile of adults with inadequate vitamin D status. Eur J Nutr. 2017;56(2):621\u201334. https:\/\/doi.org\/10.1007\/s00394-015-1106-8.","journal-title":"Eur J Nutr"},{"issue":"5","key":"1204_CR27","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3945\/ajcn.2008.27004","volume":"89","author":"A Zittermann","year":"2009","unstructured":"Zittermann A, Frisch S, Berthold HK, Gotting C, Kuhn J, Kleesiek K, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009;89(5):1321\u20137. https:\/\/doi.org\/10.3945\/ajcn.2008.27004.","journal-title":"Am J Clin Nutr"},{"key":"1204_CR28","doi-asserted-by":"publisher","unstructured":"\u2022 Abderhalden LA, Meyer S, Dawson-Hughes B, Orav EJ, Meyer U, de Godoi Rezende Costa Molino C, et al. Effect of daily 2000 IU versus 800 IU vitamin D on blood pressure among adults age 60 years and older: a randomized clinical trial. Am J Clin Nutr. 2020;112(3):527\u201337. https:\/\/doi.org\/10.1093\/ajcn\/nqaa145. The results from this uncontrolled clinical trial suggest that VD supplementation at 800 IU per day for two years may reduce mean SBP in a VD-deficient cohort of patients \u226560 years of age.","DOI":"10.1093\/ajcn\/nqaa145"},{"issue":"10022","key":"1204_CR29","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(15)01225-8.","journal-title":"Lancet"},{"issue":"18","key":"1204_CR30","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1001\/jama.2020.16909","volume":"324","author":"HA Bischoff-Ferrari","year":"2020","unstructured":"Bischoff-Ferrari HA, Vellas B, Rizzoli R, Kressig RW, da Silva JAP, Blauth M, et al. Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial. JAMA. 2020;324(18):1855\u201368. https:\/\/doi.org\/10.1001\/jama.2020.16909.","journal-title":"JAMA"},{"key":"1204_CR31","doi-asserted-by":"publisher","first-page":"106124","DOI":"10.1016\/j.cct.2020.106124","volume":"100","author":"HA Bischoff-Ferrari","year":"2021","unstructured":"Bischoff-Ferrari HA, de Godoi Rezende Costa Molino C, Rival S, Vellas B, Rizzoli R, Kressig RW, et al. DO-HEALTH: Vitamin D3 - Omega-3 - Home exercise - Healthy aging and longevity trial - Design of a multinational clinical trial on healthy aging among European seniors. Contemp Clin Trials. 2021;100:106124. https:\/\/doi.org\/10.1016\/j.cct.2020.106124.","journal-title":"Contemp Clin Trials"},{"issue":"9","key":"1204_CR32","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1002\/jbmr.431","volume":"26","author":"D Tiosano","year":"2011","unstructured":"Tiosano D, Schwartz Y, Braver Y, Hadash A, Gepstein V, Weisman Y, et al. The renin-angiotensin system, blood pressure, and heart structure in patients with hereditary vitamin D-resistance rickets (HVDRR). J Bone Miner Res. 2011;26(9):2252\u201360. https:\/\/doi.org\/10.1002\/jbmr.431.","journal-title":"J Bone Miner Res"},{"issue":"11","key":"1204_CR33","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/ajh.2012.111","volume":"25","author":"T Larsen","year":"2012","unstructured":"Larsen T, Mose FH, Bech JN, Hansen AB, Pedersen EB. Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens. 2012;25(11):1215\u201322. https:\/\/doi.org\/10.1038\/ajh.2012.111.","journal-title":"Am J Hypertens"},{"issue":"4 Pt 2","key":"1204_CR34","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/01.HYP.34.4.897","volume":"34","author":"AC Borges","year":"1999","unstructured":"Borges AC, Feres T, Vianna LM, Paiva TB. Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension. 1999;34(4 Pt 2):897\u2013901.","journal-title":"Hypertension"},{"issue":"4","key":"1204_CR35","doi-asserted-by":"publisher","first-page":"H1226","DOI":"10.1152\/ajpheart.00288.2010","volume":"299","author":"MS Wong","year":"2010","unstructured":"Wong MS, Delansorne R, Man RY, Svenningsen P, Vanhoutte PM. Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol. 2010;299(4):H1226\u201334. https:\/\/doi.org\/10.1152\/ajpheart.00288.2010.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1204_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jsbmb.2012.09.007","volume":"136","author":"S Chen","year":"2013","unstructured":"Chen S, Gardner DG. Liganded vitamin D receptor displays anti-hypertrophic activity in the murine heart. J Steroid Biochem Mol Biol. 2013;136:150\u20135. https:\/\/doi.org\/10.1016\/j.jsbmb.2012.09.007.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1\u20132","key":"1204_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jsbmb.2008.04.002","volume":"111","author":"M Thierry-Palmer","year":"2008","unstructured":"Thierry-Palmer M, Cephas S, Muttardy FF, Al-Mahmoud A. High dietary cholecalciferol increases plasma 25-hydroxycholecalciferol concentration, but does not attenuate the hypertension of Dahl salt-sensitive rats fed a high salt diet. J Steroid Biochem Mol Biol. 2008;111(1\u20132):7\u201312. https:\/\/doi.org\/10.1016\/j.jsbmb.2008.04.002.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"1204_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/BF03347275","volume":"36","author":"G Bernini","year":"2013","unstructured":"Bernini G, Carrara D, Bacca A, Carli V, Virdis A, Rugani I, et al. Effect of acute and chronic vitamin D administration on systemic renin angiotensin system in essential hypertensives and controls. J Endocrinol Invest. 2013;36(4):216\u201320. https:\/\/doi.org\/10.1007\/BF03347275.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1204_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/21551197.2016.1206499","volume":"35","author":"JAR Bricio-Barrios","year":"2016","unstructured":"Bricio-Barrios JAR, Palacios-Fonseca AJM, Del Toro-Equihua MP, Sanchez-Ramirez CAP. Effect of calcitriol supplementation on blood pressure in older adults. J Nutr Gerontol Geriatr. 2016;35(4):243\u201352. https:\/\/doi.org\/10.1080\/21551197.2016.1206499.","journal-title":"J Nutr Gerontol Geriatr"},{"issue":"1","key":"1204_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2014.04.011","volume":"235","author":"WR Chen","year":"2014","unstructured":"Chen WR, Liu ZY, Shi Y, Yin DW, Wang H, Sha Y, et al. Vitamin D and nifedipine in the treatment of Chinese patients with grades I-II essential hypertension: a randomized placebo-controlled trial. Atherosclerosis. 2014;235(1):102\u20139. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.04.011.","journal-title":"Atherosclerosis"},{"issue":"9752","key":"1204_CR41","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","volume":"376","author":"D de Zeeuw","year":"2010","unstructured":"de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet. 2010;376(9752):1543\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(10)61032-X.","journal-title":"Lancet"},{"issue":"4","key":"1204_CR42","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/HYPERTENSIONAHA.111.00659","volume":"61","author":"JP Forman","year":"2013","unstructured":"Forman JP, Scott JB, Ng K, Drake BF, Suarez EG, Hayden DL, et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension. 2013;61(4):779\u201385. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.00659.","journal-title":"Hypertension"},{"issue":"4","key":"1204_CR43","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1210\/jcem.86.4.7393","volume":"86","author":"M Pfeifer","year":"2001","unstructured":"Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001;86(4):1633\u20137. https:\/\/doi.org\/10.1210\/jcem.86.4.7393.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1204_CR44","doi-asserted-by":"publisher","first-page":"102200","DOI":"10.1016\/j.dsx.2021.102200","volume":"15","author":"R Qasemi","year":"2021","unstructured":"Qasemi R, Ghavamzadeh S, Faghfouri AH, Valizadeh N, Mohammadi A, Sayyadi H. The effect of vitamin D supplementation on flow-mediated dilatation, oxidized LDL and intracellular adhesion molecule 1 on type 2 diabetic patients with hypertension: A randomized, placebo-controlled, double-blind trial. Diabetes Metab Syndr. 2021;15(4):102200. https:\/\/doi.org\/10.1016\/j.dsx.2021.102200.","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"1204_CR45","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.0954-6820.1988.tb15789.x","volume":"223","author":"L Lind","year":"1988","unstructured":"Lind L, Lithell H, Skarfors E, Wide L, Ljunghall S. Reduction of blood pressure by treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance. Acta Med Scand. 1988;223(3):211\u20137.","journal-title":"Acta Med Scand"},{"issue":"4 Pt 1","key":"1204_CR46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/ajh\/1.4.397","volume":"1","author":"L Lind","year":"1988","unstructured":"Lind L, Wengle B, Wide L, Sorensen OH, Ljunghall S. Hypertension in primary hyperparathyroidism\u2013reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study. Am J Hypertens. 1988;1(4 Pt 1):397\u2013402. https:\/\/doi.org\/10.1093\/ajh\/1.4.397.","journal-title":"Am J Hypertens"},{"key":"1204_CR47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/978-3-030-73234-9_35","volume":"1328","author":"Y Panahi","year":"2021","unstructured":"Panahi Y, Namazi S, Rostami-Yalmeh J, Sahebi E, Khalili N, Jamialahmadi T, et al. Effect of Vitamin D Supplementation on the Regulation of Blood Pressure in Iranian Patients with Essential Hypertension: A Clinical Trial. Adv Exp Med Biol. 2021;1328:501\u201311. https:\/\/doi.org\/10.1007\/978-3-030-73234-9_35.","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"1204_CR48","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1111\/jch.13926","volume":"22","author":"V Sheikh","year":"2020","unstructured":"Sheikh V, Mozaianimonfared A, Gharakhani M, Poorolajal J, Ph D. Effect of vitamin D supplementation versus placebo on essential hypertension in patients with vitamin D deficiency: a double-blind randomized clinical trial. J Clin Hypertens (Greenwich). 2020;22(10):1867\u201373. https:\/\/doi.org\/10.1111\/jch.13926.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"9","key":"1204_CR49","first-page":"640","volume":"49","author":"R Scragg","year":"1995","unstructured":"Scragg R, Khaw KT, Murphy S. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr. 1995;49(9):640\u20136.","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"1204_CR50","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1055\/s-0033-1358453","volume":"46","author":"F Strobel","year":"2014","unstructured":"Strobel F, Reusch J, Penna-Martinez M, Ramos-Lopez E, Klahold E, Klepzig C, et al. Effect of a randomised controlled vitamin D trial on insulin resistance and glucose metabolism in patients with type 2 diabetes mellitus. Horm Metab Res. 2014;46(1):54\u20138. https:\/\/doi.org\/10.1055\/s-0033-1358453.","journal-title":"Horm Metab Res"},{"issue":"2","key":"1204_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/CIRCHEARTFAILURE.109.907899","volume":"3","author":"MD Witham","year":"2010","unstructured":"Witham MD, Crighton LJ, Gillespie ND, Struthers AD, McMurdo ME. The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail. 2010;3(2):195\u2013201. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.907899.","journal-title":"Circ Heart Fail"},{"issue":"3","key":"1204_CR52","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ijcard.2012.03.054","volume":"167","author":"MD Witham","year":"2013","unstructured":"Witham MD, Dove FJ, Khan F, Lang CC, Belch JJ, Struthers AD. Effects of vitamin D supplementation on markers of vascular function after myocardial infarction\u2013a randomised controlled trial. Int J Cardiol. 2013;167(3):745\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2012.03.054.","journal-title":"Int J Cardiol"},{"issue":"4","key":"1204_CR53","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1161\/HYPERTENSIONAHA.113.02177","volume":"63","author":"MD Witham","year":"2014","unstructured":"Witham MD, Ireland S, Houston JG, Gandy SJ, Waugh S, Macdonald TM, et al. Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial. Hypertension. 2014;63(4):706\u201312. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.02177.","journal-title":"Hypertension"},{"issue":"6","key":"1204_CR54","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/ajcn\/87.6.1738","volume":"87","author":"RP Heaney","year":"2008","unstructured":"Heaney RP, Armas LA, Shary JR, Bell NH, Binkley N, Hollis BW. 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr. 2008;87(6):1738\u201342. https:\/\/doi.org\/10.1093\/ajcn\/87.6.1738.","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"1204_CR55","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1210\/jc.2013-2653","volume":"98","author":"BW Hollis","year":"2013","unstructured":"Hollis BW, Wagner CL. Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab. 2013;98(12):4619\u201328. https:\/\/doi.org\/10.1210\/jc.2013-2653.","journal-title":"J Clin Endocrinol Metab"},{"key":"1204_CR56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mehy.2017.12.017","volume":"111","author":"R Jorde","year":"2018","unstructured":"Jorde R, Grimnes G. Serum cholecalciferol may be a better marker of vitamin D status than 25-hydroxyvitamin D. Med Hypotheses. 2018;111:61\u20135. https:\/\/doi.org\/10.1016\/j.mehy.2017.12.017.","journal-title":"Med Hypotheses"},{"issue":"1","key":"1204_CR57","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1056\/NEJMoa1109617","volume":"367","author":"HA Bischoff-Ferrari","year":"2012","unstructured":"Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012;367(1):40\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1109617.","journal-title":"N Engl J Med"},{"issue":"2","key":"1204_CR58","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1001\/jamainternmed.2015.7148","volume":"176","author":"HA Bischoff-Ferrari","year":"2016","unstructured":"Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, Staehelin HB, Meyer OW, Theiler R, et al. Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med. 2016;176(2):175\u201383. https:\/\/doi.org\/10.1001\/jamainternmed.2015.7148.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"1204_CR59","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/jgs.14679","volume":"65","author":"AA Ginde","year":"2017","unstructured":"Ginde AA, Blatchford P, Breese K, Zarrabi L, Linnebur SA, Wallace JI, et al. High-dose monthly vitamin D for prevention of acute respiratory infection in older long-term care rsidents: a randomized clinical trial. J Am Geriatr Soc. 2017;65(3):496\u2013503. https:\/\/doi.org\/10.1111\/jgs.14679.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"1204_CR60","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S2213-8587(17)30103-1","volume":"5","author":"KT Khaw","year":"2017","unstructured":"Khaw KT, Stewart AW, Waayer D, Lawes CMM, Toop L, Camargo CA Jr, et al. Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial. Lancet Diabetes Endocrinol. 2017;5(6):438\u201347. https:\/\/doi.org\/10.1016\/S2213-8587(17)30103-1.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"18","key":"1204_CR61","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1001\/jama.2010.594","volume":"303","author":"KM Sanders","year":"2010","unstructured":"Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303(18):1815\u201322. https:\/\/doi.org\/10.1001\/jama.2010.594.","journal-title":"JAMA"},{"issue":"12","key":"1204_CR62","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1093\/rheumatology\/kem240","volume":"46","author":"H Smith","year":"2007","unstructured":"Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women\u2013a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford). 2007;46(12):1852\u20137. https:\/\/doi.org\/10.1093\/rheumatology\/kem240.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1204_CR63","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1464-5491.2007.02360.x","volume":"25","author":"JA Sugden","year":"2008","unstructured":"Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2008;25(3):320\u20135. https:\/\/doi.org\/10.1111\/j.1464-5491.2007.02360.x.","journal-title":"Diabet Med"},{"issue":"10","key":"1204_CR64","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1007\/s00125-010-1838-1","volume":"53","author":"MD Witham","year":"2010","unstructured":"Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD, Struthers AD. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia. 2010;53(10):2112\u20139. https:\/\/doi.org\/10.1007\/s00125-010-1838-1.","journal-title":"Diabetologia"},{"issue":"6","key":"1204_CR65","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/S0022-2275(20)37206-0","volume":"38","author":"AB Reiss","year":"1997","unstructured":"Reiss AB, Martin KO, Rojer DE, Iyer S, Grossi EA, Galloway AC, et al. Sterol 27-hydroxylase: expression in human arterial endothelium. J Lipid Res. 1997;38(6):1254\u201360.","journal-title":"J Lipid Res"},{"issue":"1","key":"1204_CR66","doi-asserted-by":"publisher","first-page":"E138","DOI":"10.1152\/ajpendo.00303.2002","volume":"284","author":"C Theodoropoulos","year":"2003","unstructured":"Theodoropoulos C, Demers C, Petit JL, Gascon-Barre M. High sensitivity of rat hepatic vitamin D3\u201325 hydroxylase CYP27A to 1,25-dihydroxyvitamin D3 administration. Am J Physiol Endocrinol Metab. 2003;284(1):E138\u201347. https:\/\/doi.org\/10.1152\/ajpendo.00303.2002.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"13","key":"1204_CR67","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1161\/01.CIR.0000160353.27927.70","volume":"111","author":"D Somjen","year":"2005","unstructured":"Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O, et al. 25-hydroxyvitamin D3\u20131alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation. 2005;111(13):1666\u201371. https:\/\/doi.org\/10.1161\/01.CIR.0000160353.27927.70.","journal-title":"Circulation"},{"issue":"3","key":"1204_CR68","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1681\/ASN.V133621","volume":"13","author":"D Zehnder","year":"2002","unstructured":"Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, Williams MC, et al. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol. 2002;13(3):621\u20139. https:\/\/doi.org\/10.1681\/ASN.V133621.","journal-title":"J Am Soc Nephrol"},{"key":"1204_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/nu10050652","author":"J Wang","year":"2018","unstructured":"Wang J, Zhou JJ, Robertson GR, Lee VW. Vitamin D in vascular calcification: a double-edged sword? Nutrients. 2018. https:\/\/doi.org\/10.3390\/nu10050652.","journal-title":"Nutrients"},{"issue":"5","key":"1204_CR70","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/ejcn.2013.278","volume":"68","author":"ME Meekins","year":"2014","unstructured":"Meekins ME, Oberhelman SS, Lee BR, Gardner BM, Cha SS, Singh RJ, et al. Pharmacokinetics of daily versus monthly vitamin D3 supplementation in non-lactating women. Eur J Clin Nutr. 2014;68(5):632\u20134. https:\/\/doi.org\/10.1038\/ejcn.2013.278.","journal-title":"Eur J Clin Nutr"},{"issue":"12","key":"1204_CR71","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.mayocp.2013.09.012","volume":"88","author":"SS Oberhelman","year":"2013","unstructured":"Oberhelman SS, Meekins ME, Fischer PR, Lee BR, Singh RJ, Cha SS, et al. Maternal vitamin D supplementation to improve the vitamin D status of breast-fed infants: a randomized controlled trial. Mayo Clin Proc. 2013;88(12):1378\u201387. https:\/\/doi.org\/10.1016\/j.mayocp.2013.09.012.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"1204_CR72","first-page":"144","volume":"14","author":"A Dusso","year":"1994","unstructured":"Dusso A, Brown A, Slatopolsky E. Extrarenal production of calcitriol. Semin Nephrol. 1994;14(2):144\u201355.","journal-title":"Semin Nephrol"},{"issue":"3","key":"1204_CR73","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1359\/jbmr.1998.13.3.325","volume":"13","author":"MR Haussler","year":"1998","unstructured":"Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998;13(3):325\u201349. https:\/\/doi.org\/10.1359\/jbmr.1998.13.3.325.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1204_CR74","doi-asserted-by":"publisher","first-page":"e0115850","DOI":"10.1371\/journal.pone.0115850","volume":"10","author":"YT Zheng","year":"2015","unstructured":"Zheng YT, Cui QQ, Hong YM, Yao WG. A meta-analysis of high dose, intermittent vitamin D supplementation among older adults. PLoS ONE. 2015;10(1):e0115850. https:\/\/doi.org\/10.1371\/journal.pone.0115850.","journal-title":"PLoS ONE"},{"issue":"6 Suppl","key":"1204_CR75","doi-asserted-by":"publisher","first-page":"1689S","DOI":"10.1093\/ajcn\/80.6.1689S","volume":"80","author":"HF DeLuca","year":"2004","unstructured":"DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(6 Suppl):1689S-S1696. https:\/\/doi.org\/10.1093\/ajcn\/80.6.1689S.","journal-title":"Am J Clin Nutr"},{"key":"1204_CR76","doi-asserted-by":"publisher","unstructured":"Farapti F, Fadilla C, Yogiswara N, Adriani M. Effects of vitamin D supplementation on 25(OH)D concentrations and blood pressure in the elderly: a systematic review and meta-analysis. F1000Res. 2020;9:633. https:\/\/doi.org\/10.12688\/f1000research.24623.3.","DOI":"10.12688\/f1000research.24623.3"},{"issue":"19","key":"1204_CR77","doi-asserted-by":"publisher","first-page":"e15284","DOI":"10.1097\/MD.0000000000015284","volume":"98","author":"S He","year":"2019","unstructured":"He S, Hao X. The effect of vitamin D3 on blood pressure in people with vitamin D deficiency: A system review and meta-analysis. Medicine (Baltimore). 2019;98(19):e15284. https:\/\/doi.org\/10.1097\/MD.0000000000015284.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"1204_CR78","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.numecd.2014.02.015","volume":"24","author":"A Dalbeni","year":"2014","unstructured":"Dalbeni A, Scaturro G, Degan M, Minuz P, Delva P. Effects of six months of vitamin D supplementation in patients with heart failure: a randomized double-blind controlled trial. Nutr Metab Cardiovasc Dis. 2014;24(8):861\u20138. https:\/\/doi.org\/10.1016\/j.numecd.2014.02.015.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"1204_CR79","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/MBP.0000000000000091","volume":"20","author":"H Mozaffari-Khosravi","year":"2015","unstructured":"Mozaffari-Khosravi H, Loloei S, Mirjalili MR, Barzegar K. The effect of vitamin D supplementation on blood pressure in patients with elevated blood pressure and vitamin D deficiency: a randomized, double-blind, placebo-controlled trial. Blood Press Monit. 2015;20(2):83\u201391. https:\/\/doi.org\/10.1097\/MBP.0000000000000091.","journal-title":"Blood Press Monit"},{"issue":"5","key":"1204_CR80","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamainternmed.2015.0237","volume":"175","author":"LA Beveridge","year":"2015","unstructured":"Beveridge LA, Struthers AD, Khan F, Jorde R, Scragg R, Macdonald HM, et al. Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data. JAMA Intern Med. 2015;175(5):745\u201354. https:\/\/doi.org\/10.1001\/jamainternmed.2015.0237.","journal-title":"JAMA Intern Med"},{"key":"1204_CR81","doi-asserted-by":"publisher","first-page":"E03","DOI":"10.5888\/pcd17.190307","volume":"17","author":"D Zhang","year":"2020","unstructured":"Zhang D, Cheng C, Wang Y, Sun H, Yu S, Xue Y, et al. Effect of vitamin D on blood pressure and hypertension in the general population: an update meta-analysis of cohort studies and randomized controlled trials. Prev Chronic Dis. 2020;17:E03. https:\/\/doi.org\/10.5888\/pcd17.190307.","journal-title":"Prev Chronic Dis"},{"issue":"5","key":"1204_CR82","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.0954-6820.1987.tb10959.x","volume":"222","author":"L Lind","year":"1987","unstructured":"Lind L, Wengle B, Ljunghall S. Blood pressure is lowered by vitamin D (alphacalcidol) during long-term treatment of patients with intermittent hypercalcaemia. A double-blind, placebo-controlled study. Acta Med Scand. 1987;222(5):423\u20137.","journal-title":"Acta Med Scand"},{"issue":"6","key":"1204_CR83","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.clnu.2013.01.020","volume":"32","author":"A Breslavsky","year":"2013","unstructured":"Breslavsky A, Frand J, Matas Z, Boaz M, Barnea Z, Shargorodsky M. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr. 2013;32(6):970\u20135. https:\/\/doi.org\/10.1016\/j.clnu.2013.01.020.","journal-title":"Clin Nutr"},{"issue":"8","key":"1204_CR84","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3945\/jn.111.154005","volume":"142","author":"S Muldowney","year":"2012","unstructured":"Muldowney S, Lucey AJ, Hill TR, Seamans KM, Taylor N, Wallace JM, et al. Incremental cholecalciferol supplementation up to 15 mug\/d throughout winter at 51\u201355 degrees N has no effect on biomarkers of cardiovascular risk in healthy young and older adults. J Nutr. 2012;142(8):1519\u201325. https:\/\/doi.org\/10.3945\/jn.111.154005.","journal-title":"J Nutr"},{"issue":"10","key":"1204_CR85","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1097\/HJH.0b013e32832f075b","volume":"27","author":"MD Witham","year":"2009","unstructured":"Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens. 2009;27(10):1948\u201354. https:\/\/doi.org\/10.1097\/HJH.0b013e32832f075b.","journal-title":"J Hypertens"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-022-01204-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-022-01204-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-022-01204-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T11:43:19Z","timestamp":1664019799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-022-01204-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":85,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1204"],"URL":"https:\/\/doi.org\/10.1007\/s11906-022-01204-6","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"assertion":[{"value":"1 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}